Sankyo Sues Nissin Over Mevalotin Patent
Sankyo’s action follows Nissin’s recent launch of a generic version of the product, called Mevarich, following the expiration of Mevalotin's patent in October 2002.
With the main patent expired, Sankyo is suing Nissin based on a patent for the technology to keep Mevalotin tablets stable.
Around 30 companies are currently developing generic versions of Mevalotin with...
To view the full article, register now.